We present a case of an adult female patient with a history of Evan's syndrome treated with prior splenectomy and rituximab who subsequently developed panhypogammaglobulinemia after which, despite receiving antibody replacement, she developed a progressive and ultimately fatal meningoencephalitis due to human Coxsackie B3 virus.